Diagnosing SM: What is the Darier’s sign?
The Darier’s sign is not a definitive test for SM, but it’s one of many tests that doctors may use to help get closer to a diagnosis.
The Darier’s sign is not a definitive test for SM, but it’s one of many tests that doctors may use to help get closer to a diagnosis.
Abnormal and overactive mast cells can accumulate in many different areas of the body, including the lungs.
Mast cell activation causes tryptase to be released into the bloodstream, raising serum tryptase counts.
Advanced SM is associated with marked increases in five- and ten-year mortality, with nonadvanced SM also having impacts on mortality.
ST2, a receptor that binds with interleukin-33, is elevated in patients with SM and may be a biomarker and future therapeutic target.
The primary method of managing urticaria pigmentosa involves avoiding your triggers.
Landmarks worldwide will light up on Rare Disease Day.
A recent study found that having SM may increase the risk of eclampsia but decrease the risk of abortive outcome in pregnancy.
The PATHFINDER clinical trial demonstrated that avapritinib leads to durable treatment responses and a favorable risk-benefit profile.
A 13-year-old female was diagnosed with mast cell leukemia, a type of SM, and stage IV ovarian mixed germ cell tumor.